1.
Wysocki PJ. Commentary [to: "Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma. "]. OncoReview [Internet]. 2011Feb.28 [cited 2024Nov.23];1(1(1):71-2. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/232